Medical Insights from Industry

RSS

"Insights from Industry" is a dynamic series of interviews at the cutting edge of the medical industry. Every interviewee is a leader in their particular field and is handpicked to give an informative and accessible insight into their chosen field. These interviews are guaranteed to keep you in the know in a rapidly changing industry.

Crowdsourcing: the answer for rare disease diagnosis?

Medical crowdsourcing is like the ultimate consult service. A question arises, it is asked on the forum, and you can get answers from multiple specialties within minutes. It is harnessing the brightest minds in one place and using that power to do what we enjoy doing most – helping people.

4 Jan 2016

Mitochondrial variation and viable pregnancy: an interview with Dr Elpida Fragouli

Embryos require adequate amounts of energy so that they can successfully progress through each of their cell divisions.

16 Dec 2015

Advances in clinical chemistry: an interview with Trevor McCarthy

Altair 240 analyzer is a compact, fully automated random access benchtop analyzer, supported by a full range of barcoded, liquid stable, ready to use reagents.

From EKF Diagnostics 14 Dec 2015

Testing for developmental delay through an app? An interview with Dr. Clara Lajonchere

Cognoa's app helps every parent find out if their child’s development is on track and, if not, get their child the right help as early as possible.

8 Dec 2015

Advances in leadless pacing: an interview with Dr. Reddy

Pacemakers have been around for a very long time, they're great devices, critical for many people who have slow heartbeats. While they're very effective, they have some issues. There are two main aspects relating to these issues.

1 Dec 2015

Keeping employees healthy: an interview with Clare Sicklen, HR Director, Johnson & Johnson Consumer

Our approach to health at work dates back to our Credo which was crafted by our former chairman Robert Wood Johnson in 1943.

23 Nov 2015

Treating insomnia through a CBT device? An interview with Dr Ebrahim

Insomnia refers to a clinical condition that is characterised by one or more of the following – difficulty initiating sleep and/or maintaining sleep and/or waking up too early AND associated with symptoms the next day such as sleepiness, lethargy, loss of concentration.

16 Nov 2015

Scalable production of gene therapy vectors: an interview with Frank Ubags

Gene therapy involves introducing genetic material into cells to replace missing or malfunctioning genes or to add a gene to express a beneficial protein in order to treat certain diseases, such as cancer or inherited disorders.

26 Oct 2015

Diabetic retinopathy therapy innovations: an interview with Richard Kirk, CEO of Polyphotonix

In the UK there are currently over 3.5 million people who have diabetes, with a growth rate exceeding 280,000 people per year. Diabetic retinopathy is the most common complication of diabetes.

19 Oct 2015

Genetic carrier screening: an interview with Don Hardison, CEO of Good Start Genetics

Carrier screening provides you and your doctor with information about your risks of having a child with a serious genetic disease prior to or during pregnancy.

6 Oct 2015

How feasible is telesurgery? An interview with Dr Roger Smith, CTO, Florida Hospital Nicholson Center

Telesurgery, or remote surgery, is the ability for a doctor to perform surgery on a patient even though they are not physically in the same location.

5 Oct 2015

Using deep learning to analyze genetic mutations: an interview with Brendan Frey

To understand deep learning in the context of genetic disease, you need to understand shallow learning first. Shallow learning relates mutations to diseases by looking for mutations that commonly occur in patients with a disease. It’s a commonly used method.

21 Sep 2015

Using integrated molecular pathology to manage incidental pancreatic cysts: an interview with Dr Ananya Das

Pancreatic cystic neoplasms, or PCNs, are a subset of all pancreatic cysts that are found on the pancreas. PCNs are neoplastic cysts that span a biological spectrum from benign to malignant.

15 Sep 2015

Reducing hospital readmissions through Transitional Care: an interview with Rani Khetarpal

Services provided to a patient whose medical and/or psychosocial problems require moderate or high-complexity medical decision making during transitions in care from an inpatient setting, partial hospital, observation status in a hospital, or skilled nursing facility to the patient’s community setting.

27 Aug 2015

Applying a top restaurant model to healthcare communications: an interview with Brandi Robinson, Sanofi

Communications professionals often are expected to be experts in all facets of the vast spectrum of communications, from brand, corporate, crisis and digital communications to corporate reputation and channel strategy and everything in between.

From Sanofi 19 Aug 2015

Voice cloning: an interview with Paul Welham, CEO, CereProc

CereVoice Me was essentially designed for those who had been diagnosed with MND/ALS and other illnesses that may cause an individual to lose the power of speech. CereProc identified that there was a gap in the market and pulled our resources together to build CereVoice Me, the goal of the service is to build a TTS voice efficiently and at a cost effective price.

27 Jul 2015

Multiple sclerosis relapse management: an interview with Gina Remington

MS relapses are typically reflective of new neurological symptoms. However, it can be a worsening of neurologic symptoms that begins after a patient has been stable (generally for about 30 days), but relapses are persistent and consistent changes in symptoms that occur for more than 24 to 48 hours.

26 Jul 2015

Innovation in anaesthesia: an interview with Matti Lehtonen, GE Healthcare

The spectrum of patients seen today, from pre-term infants to the morbidly obese to the longer living elderly, is wider than ever before and increasingly more challenging with patients often presenting with multiple co-morbidities. This puts a huge strain on healthcare providers who are facing increasing challenges such as cost pressure and staff shortages.

14 Jul 2015

Artemisinin and the fight against malaria: an interview with Dr. Robert Sebbag, Sanofi

Since 2014, more than 16 million anti-malarial treatments derived from the Sanofi patented process for semi-synthetic artemisinin have been supplied to endemic countries in Africa.

From Sanofi 28 Jun 2015

NHS access - are you ready? An interview with Dr Keith Morris, Morris Healthcare Consulting

The NHS is under immense pressure not only to continue to deliver improved care but also to change how it is delivering care to meet rising and changing demand with an essentially fixed amount of money and resources - all at the same time. Patience and persistence with good humour are thus vital characteristics to have.

23 Jun 2015